Does Marijuana Lower Your Immune System? A Scientific Look

Marijuana does not simply “lower” the immune system like flipping a switch. The reality is more complex: cannabis compounds shift immune activity up or down depending on the specific compound involved, the dose, the method of consumption, the tissue affected, and even the age of the user. THC, the psychoactive component, tends to suppress several branches of immune function, while CBD often reduces inflammation without broadly dampening immune defenses. And smoking cannabis introduces an entirely separate set of immune problems that have nothing to do with cannabinoids themselves. The honest picture is one of modulation rather than straightforward suppression, and whether that modulation helps or hurts you depends heavily on context.

Why Immune Cells Respond to Cannabis at All

Your body already makes its own cannabis-like molecules called endocannabinoids, and your immune cells are covered in the receptors that detect them. The receptor most relevant to immunity is called CB2, and it is found in especially high concentrations on immune cells. Research measuring receptor levels across different blood cell types found a consistent hierarchy: B cells carry the most CB2, followed by natural killer cells, then monocytes, neutrophils, and finally T cells.¹ In immune-rich tissues like the spleen and tonsils, CB2 levels rival CB1 levels in the brain, which gives you a sense of how deeply wired the immune system is to respond to cannabinoid signaling.

This built-in system exists for a reason. Research in mice has shown that the endocannabinoid system plays a role in keeping gut immunity balanced, helping regulate a population of immune cells that prevent the body from attacking its own tissues.² When you introduce THC or CBD from marijuana, you are essentially flooding a regulatory system that is already managing immune activity on its own. Whether that flood calms useful inflammation or disables necessary defenses depends on what is happening in the body at the time.

THC and CBD Do Different Things to Immunity

Lumping all cannabis effects together is one of the biggest mistakes people make when asking whether marijuana is bad for the immune system. THC and CBD, the two most abundant compounds in the plant, push immunity in meaningfully different directions.

THC tends to suppress immune function broadly. It dials down the production of several signaling molecules that immune cells use to coordinate an attack against pathogens. In laboratory studies on human immune cells, both THC and CBD reduced levels of key inflammatory signals like IL-6 and TNF-α when those cells were provoked with bacterial toxins.³ That sounds like both compounds do the same thing, but the scope matters. A comprehensive review of the literature found that THC generally acts as an immunosuppressant, while CBD reduces inflammation without broadly weakening immune defenses.⁴

A striking example of this divergence comes from phagocytosis, the process by which immune cells engulf and destroy invaders. An older lab study found that THC severely impaired the ability of mouse macrophages to internalize particles, essentially disabling their core function.⁵ By contrast, a study testing a CBD-rich cannabis fraction on human macrophages found the opposite: CBD treatment increased macrophage polarization and substantially boosted their ability to swallow silica particles, suggesting enhanced phagocytosis.⁶ So while THC may blunt a key front-line defense, CBD appears capable of strengthening it under certain conditions.

Both compounds also show complex, cell-type-specific effects on cytokine production. When researchers tested THC and CBD on different human immune cell lines, they found that the impact varied depending on which cells were involved and which signaling molecules were measured.⁷ The takeaway is that neither compound has a simple on-off effect. A high-THC strain and a high-CBD strain are not doing the same thing to your immune system.

Smoking Changes the Equation Dramatically

Much of the public concern about marijuana and immunity comes from studies on people who smoke it, and those studies do show real immune suppression in the lungs. But it is important to separate the effects of combustion from the effects of cannabinoids. Burning plant material of any kind produces tar, particulates, and toxic gases that damage airway tissue and impair the immune cells stationed there.

The evidence on this front is fairly consistent. Alveolar macrophages, the immune cells that patrol the airways and destroy inhaled bacteria, perform poorly in regular cannabis smokers. These cells become engorged with tar and particulates, and when challenged with common respiratory bacteria like Staphylococcus aureus, they show deficient phagocytosis and bacterial killing. They also produce lower levels of several protective immune signals compared to both nonsmokers and tobacco-only smokers.⁸ Separate research has confirmed that regular marijuana smokers develop structural abnormalities in alveolar macrophages along with impaired antimicrobial and tumor-killing function.⁹

If you assume vaping sidesteps these problems, the picture is less reassuring than you might expect. A study comparing cannabis smoke extract and cannabis vape extract on human bronchial cells found that both triggered similar gene-level responses, upregulating pathways related to inflammation and cellular stress while downregulating pathways involved in lipid metabolism and cell repair.¹⁰ Vaping does eliminate many of the particulates from combustion, but it still delivers heated compounds that provoke the lung’s inflammatory machinery. For people specifically concerned about lung immunity, neither delivery method is without cost.

What Blood Tests Tell Us About Cannabis and Inflammation

If marijuana broadly suppressed the immune system, you would expect regular users to show elevated markers of immune dysfunction or, conversely, lower levels of inflammatory markers that normally keep the body vigilant. The population-level data paints an interesting picture.

A large analysis using U.S. national health survey data from adults aged 20 to 59 found that recent cannabis smokers generally had lower levels of C-reactive protein (CRP), a widely used marker of systemic inflammation, compared to people who had never smoked cannabis.¹¹ That finding initially seems to support the idea that cannabis calms inflammation, but other research complicates it. A separate study examining self-reported cannabis use and multiple inflammatory biomarkers found that the associations were statistically imprecise for CRP, IL-6, and fibrinogen, meaning there was no clear, reliable link in either direction.¹² And a study specifically looking at physically active chronic cannabis users found no significant differences in CRP, IL-6, or cortisol compared to non-users.¹³

These observational studies have a common limitation: cannabis users differ from non-users in dozens of ways beyond their cannabis consumption. Research attempting to isolate the effect of cannabis has adjusted for factors like tobacco use, alcohol intake, and body mass index, but confounding is difficult to fully eliminate in this kind of study.¹⁴ The overall pattern suggests that regular cannabis use does not cause obvious, measurable immune dysfunction in standard blood tests for the average healthy adult. But these markers are blunt instruments that would not pick up the kind of localized lung damage described above.

What We Learn From HIV Research

Some of the most informative real-world data on cannabis and immune function comes from people living with HIV, because that population is closely monitored for immune cell counts. The findings are, to put it mildly, not what you would predict if cannabis were straightforwardly immunosuppressive.

One study of Black adults living with HIV found that participants who tested positive for THC had significantly higher CD4+ T-cell counts (about 621 versus 524) and higher CD8+ counts than those who tested negative for THC, even after adjusting for demographic and HIV-related factors.¹⁵ CD4+ cells are the very immune cells that HIV destroys, so higher counts in cannabis users caught researchers’ attention.

However, a larger longitudinal study of people with HIV found a more complicated story. Cannabis use was not significantly associated with differences in CD4+ T-cell counts across multiple measures, but it was associated with roughly double the odds of having a detectable viral load at any given visit.¹⁶ That last finding likely reflects the practical reality that people who use cannabis may be less consistent with their antiretroviral medication regimens, not that cannabis itself is boosting viral replication. It is a useful reminder that in real-world studies, behavioral confounders can easily masquerade as biological effects.

The pneumonia data adds another wrinkle. Despite the impaired lung macrophage function seen in laboratory studies, a cohort study of both HIV-infected and HIV-uninfected men found that weekly or daily marijuana use was not significantly associated with increased pneumonia risk in HIV-uninfected men.¹⁷ In fact, the point estimates trended lower with more frequent use among HIV-negative participants, though none of these differences reached statistical significance. That said, other reviews have noted that cannabis smoking has been linked to pneumonia in some clinical contexts.¹⁸ The disconnect between lab findings and population outcomes suggests that the immunosuppressive effects seen in test tubes may be partially compensated for in the complex environment of a living body.

Adolescent Exposure Is a Different Story

One of the clearest warnings from the research concerns age at exposure. A mouse study simulating frequent low-dose THC use during adolescence found lasting disruption of microglia, the resident immune cells of the brain. These mice entered young adulthood with broadly altered immune gene expression in the brain, and their microglia failed to mount appropriate responses when exposed to either bacterial toxins or social stress. Crucially, the same THC regimen given to young adult mice did not produce the same effects, and the adolescent disruption faded with further aging.¹⁹

This finding matters because the brain’s immune system during adolescence is still developing, and microglia play roles not only in fighting infections but also in pruning neural connections. The fact that a peripheral CB1 receptor blocker prevented the damage suggests the effect travels through the body’s cannabinoid signaling system, not through some nonspecific toxic mechanism. While this is a mouse study and direct translation to human teenagers requires caution, it aligns with broader concerns about cannabis use during adolescent brain development.

Chronic Use and Immune Tolerance

What happens to the immune system if you use cannabis daily for weeks or months? The body does develop tolerance to many of THC’s effects, but immune suppression does not resolve as neatly. In mice given psychoactive doses of THC daily, tolerance to pain-relieving effects developed within a week, but immune parameters continued to be suppressed. After two weeks of chronic exposure, natural killer cell activity was still about 37% below normal, a key signaling molecule called interferon-gamma was still down by about 40%, and the balance of immune cell populations in the spleen had shifted, with T cells declining by about 20% and B cells increasing by about 26%.²⁰

This is one of the more sobering findings in the literature. A regular user might feel that their body has “adjusted” to cannabis because the high becomes more familiar and some side effects fade, but the immune effects appear to persist on a different timeline. Natural killer cells are the body’s first-line defense against virus-infected cells and certain tumor cells, so a sustained 37% reduction in their activity is not trivial, even in a mouse model.

When Immune Suppression Is the Goal

For the roughly 5-8% of people worldwide who have an autoimmune disease, a dampened immune response is not a side effect to worry about. It is something their doctors actively try to achieve with medications that carry far worse side-effect profiles than cannabis.

Research has identified the CB2 receptor as a potential therapeutic target for autoimmune conditions including rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.²¹ The logic is straightforward: if cannabinoids can quiet overactive immune cells, they might help in diseases where those cells are attacking the body’s own tissues. In the experimental autoimmune encephalomyelitis model, used to study multiple sclerosis, cannabinoid compounds have shown the ability to suppress the immune responses driving the disease.²²

There is also interest in CBD’s ability to calm cytokine storms, the runaway inflammatory responses that cause damage in severe infections. A review of the literature found that CBD shows promise in reducing immune cell recruitment and the surge of inflammatory molecules in tissues affected by viral infections like SARS-CoV-2.²³ The idea is not that CBD fights the virus itself, but that it might reduce the collateral damage caused by the immune system’s overreaction. This remains early-stage research, but it illustrates how the immune-modulating properties of cannabis compounds cut in multiple directions depending on the clinical situation.

Beyond THC and CBD

Cannabis contains well over a hundred cannabinoids and many terpenes, and some of these minor compounds interact with the immune system in their own right. Beta-caryophyllene, a terpene found in cannabis as well as black pepper and cloves, is a selective CB2 receptor activator with documented anti-inflammatory and immunomodulatory properties.²⁴ Because it activates CB2 without binding to CB1, it does not produce a high, which makes it an interesting candidate for therapeutic use.

The presence of these additional compounds is one reason why studies using whole-plant cannabis extracts sometimes produce different immune effects than studies using purified THC or CBD alone. Researchers have described an “entourage effect” in which the combined action of multiple cannabinoids and terpenes produces outcomes that do not match the sum of the individual compounds. For the average person trying to understand whether marijuana affects their immune system, this means the specific strain and product matters in ways that go beyond just the THC-to-CBD ratio listed on the label.

Contaminants as a Separate Immune Threat

A frequently overlooked factor in the real-world immune effects of marijuana is contamination. Cannabis products can harbor microbes, heavy metals, and pesticide residues, each of which poses its own risk to immune health entirely independent of the cannabinoids. A review of cannabis contaminants found that common issues include fungal and bacterial contamination, heavy metal accumulation from soil, and pesticide residues from cultivation, with potential human effects including infection and developmental harm.²⁵

This matters most for immunocompromised users: people on chemotherapy, organ transplant recipients, or those with advanced HIV. For these individuals, inhaling fungal spores from contaminated cannabis can cause serious, sometimes fatal lung infections that have nothing to do with cannabinoid pharmacology. Regulated dispensaries in legal markets typically test products for mold, heavy metals, and pesticides, but unregulated products carry no such guarantees. If you are worried about cannabis and your immune system, the purity of what you are consuming may matter as much as the cannabinoid content itself.